Study of BT02 for advanced lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new drug called BT02 for people with advanced lung cancer that has not responded to previous treatments. It aims to see if the drug can help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced non-small cell or small cell lung cancer that has spread or come back, and standard treatments have stopped working.
- You are well enough to be up and about (ECOG score 0-1) and expected to live at least 3 more months.
- You have at least one tumor outside the brain that can be measured.
- You do not have certain gene changes in your cancer that would make other targeted treatments more suitable.
- You are willing to use effective birth control during the study if you or your partner could have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell therapy called BST08, made from your own immune cells, for advanced non-small cell lung cancer that has not responded to at least two standard treatments. The goal is to see if this therapy is safe and can help shrink tumors.
This Phase 2 study tests a combination of two experimental medicines in people with advanced or metastatic solid cancers, including non-small cell lung cancer and nasopharyngeal cancer. It aims to see whether the drugs can shrink tumors and improve outcomes, while carefully checking safety and eligibility.
This trial tests an experimental drug called TUB-040 for people with advanced non-small cell lung cancer that has spread or cannot be removed by surgery. The drug is designed to target and attack cancer cells while sparing healthy tissue, potentially slowing the cancer's growth.
This Phase 2 trial tests how well two study drugs (and a combination of them) work in people with extensive-stage small cell lung cancer. It’s mainly for patients whose cancer has come back or who couldn’t tolerate at least some standard treatments, and it aims to see if treatment can shrink tumors and be tolerable.
This trial tests a new drug, BA1302, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to see if BA1302 is safe and effective.
This trial tests a new drug, BL-M09D1, in people with advanced non-small cell lung cancer or other solid tumors that have not responded to standard treatments. The goal is to see if the drug can help shrink or control the cancer.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.